| 000 | 01241 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513154759.0 | ||
| 264 | 0 | _c19990216 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/42.4.555 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnson, D M | |
| 245 | 0 | 0 |
_aIn-vitro activity of a combination of two oral beta-lactams (cefpodoxime and amoxycillin) against Streptococcus pneumoniae isolates with reduced susceptibilities to penicillin. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cOct 1998 |
||
| 300 |
_a555-7 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAmoxicillin _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aCeftizoxime _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aPenicillin Resistance |
| 650 | 0 | 4 |
_aStreptococcus pneumoniae _xdrug effects |
| 650 | 0 | 4 | _aCefpodoxime |
| 700 | 1 | _aJones, R N | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 42 _gno. 4 _gp. 555-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/42.4.555 _zAvailable from publisher's website |
| 999 |
_c9782966 _d9782966 |
||